Warren Roiter

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

Part of Flynn Pharma Ltd., Flynn Pharma (Holdings) Ltd. is a privately held British pharmaceutical company that works across various medical fields including psychiatry, paediatric medicine, post-operative pain management, anti-infective and emergency medicine. Flynn Pharma (Holdings is based in Stevenage, UK. The company provides healthcare professionals with NDD and women's health education, training, resources, events and product information.

Part of Flynn Pharma Ltd., Flynn Pharma (Holdings) Ltd. is a privately held British pharmaceutical company that works across various medical fields including psychiatry, paediatric medicine, post-operative pain management, anti-infective and emergency medicine. Flynn Pharma (Holdings is based in Stevenage, UK. The company provides healthcare professionals with NDD and women's health education, training, resources, events and product information.

Part of Flynn Pharma Ltd., Flynn Pharma (Holdings) Ltd. is a privately held British pharmaceutical company that works across various medical fields including psychiatry, paediatric medicine, post-operative pain management, anti-infective and emergency medicine. Flynn Pharma (Holdings is based in Stevenage, UK. The company provides healthcare professionals with NDD and women's health education, training, resources, events and product information.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

Trevi Management LP (Trevi Health Capital) is a private equity firm founded in 2005 by David Robbins and Andrew Fink. The firm is headquartered in New York with an additional office in London.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

Trevi Management LP (Trevi Health Capital) is a private equity firm founded in 2005 by David Robbins and Andrew Fink. The firm is headquartered in New York with an additional office in London.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

Trevi Management LP (Trevi Health Capital) is a private equity firm founded in 2005 by David Robbins and Andrew Fink. The firm is headquartered in New York with an additional office in London.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.